AN AUDIT OF ADHERENCE TO ANTI-TNF THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

被引:2
|
作者
Duncan, J. [1 ]
Sastrillo, M. [1 ]
Baker, J. [2 ]
Younge, L. [2 ]
Anderson, S. [1 ]
Lindsay, J. [2 ]
Sanderson, J. [1 ]
Irving, P. [1 ]
机构
[1] Guys & St Thomas NHS Fdn Trust, Dept Gastroenterol, London, England
[2] Barts & London NHS Trust, Dept Gastroenterol, London, England
关键词
Adalimamab; Adherence; Anti-TNF therapy; Inflammatory Bowel Disease; infliximab; Medication Adherence Report Scale;
D O I
10.1136/gut.2011.239301.300
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Anti-TNF Treatment in Inflammatory Bowel Disease
    Yapali, Suna
    Hamzaoglu, Hulya Over
    ANNALS OF GASTROENTEROLOGY, 2007, 20 (01): : 48 - 53
  • [42] ACTIVE TUBERCULOSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AFTER TREATMENT WITH ANTI-TNF THERAPY
    Owen, L.
    Thi, A. A.
    Bouri, S.
    Wolfson, P.
    Abbara, A.
    John, L.
    Davidson, R. N.
    Hart, A. L.
    GUT, 2016, 65 : A252 - A253
  • [43] ADVERSE EVENTS IN ELDERLY INFLAMMATORY BOWEL DISEASE PATIENTS MANAGED WITH ANTI-TNF THERAPY
    Winters, Conchubhair
    Mooney, Peter
    GUT, 2018, 67 : A101 - A101
  • [44] Clinical features of tuberculosis infection in inflammatory bowel disease patients on anti-TNF therapy
    Estevez-Gil, M.
    De Castro, M. L.
    Hernandez, V.
    Pineda, J. R.
    Martinez-Cadilla, J.
    Pereira, S.
    Rodriguez-Prada, J-I
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S309 - S309
  • [45] Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease
    Santella, Christina
    Bitton, Alain
    Filliter, Christopher
    Bessissow, Talat
    Vutcovici, Maria
    Lakatos, Peter L.
    Brassard, Paul
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (02) : 176 - 182
  • [46] Increased Discontinuation Rates of Anti-TNF Therapy in Elderly Inflammatory Bowel Disease Patients
    de Jong, M. E.
    Smits, L. J. T.
    van Ruijven, B.
    den Broeder, N.
    Russel, M. G. V. M.
    Romkens, T. E. H.
    West, R. L.
    Jansen, J. M.
    Hoentjen, F.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (07): : 888 - 895
  • [47] Effect of antinuclear antibodies on pharmacokinetics of anti-TNF therapy in patients with Inflammatory Bowel Disease
    Theodoraki, E.
    Orfanoudaki, E.
    Foteinogiannopoulou, K.
    Andreou, N. P.
    Gazouli, M.
    Koutroubakis, I.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I354 - I355
  • [48] Guide to Discussing the Risks of Immunomodulator and Anti-TNF Therapy with Inflammatory Bowel Disease Patients
    Siegel, Corey A.
    PRACTICAL GASTROENTEROLOGY, 2007, 31 (11) : 14 - +
  • [49] Role of Thiopurine and Anti-TNF Therapy in Lymphoma in Inflammatory Bowel Disease
    Herrinton, Lisa J.
    Liu, Liyan
    Weng, Xiaoping
    Lewis, James D.
    Hutfless, Susan
    Allison, James E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (12): : 2146 - 2153
  • [50] Inflammatory bowel disease as a paradoxical effect of anti-TNF alpha therapy
    Iriarte, Ainara
    Zaera, Celia
    Bachiller-Corral, Javier
    Lopez-Sanroman, Antonio
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2017, 40 (02): : 117 - 121